Upload
norah-mosley
View
218
Download
2
Tags:
Embed Size (px)
Citation preview
USE OF ACUTE HEPATITIS USE OF ACUTE HEPATITIS SURVEILLANCE TO SURVEILLANCE TO
EVALUATE PROGRAM FOR EVALUATE PROGRAM FOR VIRAL HEPATITIS VIRAL HEPATITIS
PREVENTION AND CONTROLPREVENTION AND CONTROL
Central Asian Program, DIH, EPO, CDC
Acute Hepatitis Incidence,Acute Hepatitis Incidence,KyrgyzstanKyrgyzstan, 1990-2002, 1990-2002
597,4
475,3394
474,8431,8445,5
278,6
590,3
326,2
201,8
429,9
229,9152,5
597,4
475,3394
474,8431,8445,5
278,6
590,3
326,2
201,8
429,9
229,9152,5
0
100
200
300
400
500
600
700
Years
Inc
ide
nc
e
Weaknesses of the Acute Hepatitis Weaknesses of the Acute Hepatitis Surveillance Used before 2000Surveillance Used before 2000
– Acute hepatitis case definition was not applied
– Cases were not serologically tested for specific markers of acute hepatitis A,B,C and D
– Epidemiological data collection procedure Epidemiological data collection procedure and analysis methodology were not and analysis methodology were not standardizedstandardized
Sentinel Surveillance IntroductionSentinel Surveillance Introduction ((goalsgoals))
• To provide reliable etiological diagnostics of acute viral hepatitis on bases of representative sample
• To define risk groups and risk factors for acute hepatitis
• To use surveillance data for design, monitoring and evaluation of programs for viral hepatitis control and prevention
• To provide database for epidemiological studies
Sentinel Surveillance Introduction Sentinel Surveillance Introduction ((stagesstages 1) 1)
• National Reference Laboratory was established; standard laboratory procedures and quality assurance were provided
• External Quality Assessment of the accuracy of Reference laboratory results was conducted in CDC, Atlanta
• Corresponding Ministry of Health orders were issued
• Sentinel Sites were organized in three regions: Bishkek, Naryn and Jalal-Abad
Sentinel Surveillance Introduction Sentinel Surveillance Introduction ((stagesstages 22))
• The structure and procedure of sentinel surveillance were developed, including:– sample size and sampling design– acute hepatitis case definition– algorism of laboratory testing– acute hepatitis case classification– standard questionnaire for epidemiological data collection– blood samples collection and transportation
• 4 trainings have been conducted for the sentinel sites personnel (laboratory workers, physicians, epidemiologists, nurses) on sentinel surveillance structure and operating, data quality assurance
Acute Hepatitis Case
Infectious Hospital(physician, nurse)
- confirmation of correspondence to case definition- filling in and marking of the questionnaire - blood sample collection and marking - transportation of samples and questionnaires to the State Sanitation and Epidemiological Surveillance Center
State Sanitary and Epidemiological Surveillance Center
(epidemiologist, laboratory worker)
- serum separation - transportation of samples and questionnaires to the Reference Laboratory
Reference Laboratory(epidemiologist, laboratory worker)
- laboratory testing- data entering- data analysis and report preparation
Ministry of Health
State Department of Sanitation and Epidemiological
Surveillance
Regional health authorities and State Sanitation and Epidemiological Surveillance Centers
report report report
Algorithm of Laboratory TestingAlgorithm of Laboratory Testing
Blood sample
HBsAgIgM
anti-HBcIgM
anti-HAVTotal
anti-HCV
Anti-HDV
+
GNP/capitaGNP/capita ((USDUSD) 1994-2000) 1994-2000
Country/Years 1994 2000 (estimate for 2002)
GNP increase
Kazakhstan 721 1230 70.6%
Kyrgyzstan 275.3 286 4%
Tajikistan 159.1 159,8 0.4%
Turkmenistan 517 552,5 6.9%
Uzbekistan 255.4 264,3 3.4%European Bank for Reconstruction and Development. Transition Report Update, May 2002.
Aims: Aims:
• To evaluate parenteral hepatitis risk factors
• To assess an impact of universal newborn Hepatitis B immunization program
Materials and MethodsMaterials and Methods ((11))
• Study design: matched case control study (1 case + 2 controls matched by age, sex and place of residence)
• Cases: acute hepatitis B, C and D cases (parenteral hepatitis), 2000-2003
• Controls: acute hepatitis A cases, 2000-2003 • N = 214 case-control sets• EPI INFO matched case-control analysis
followed by conditional logistic regression
Risk Factors Risk Factors ((6 months prior to the onset of disease6 months prior to the onset of disease))
• Blood transfusion• Surgery• Injections in hospital• Injections in polyclinic• Blood samples collection in polyclinic• Visit to surgeon, dentist, urologist, gynecologist• Blood donation• Multiple sexual partners• STD
Risk Factors of Parenteral Risk Factors of Parenteral HepatitisHepatitis ( (monovariate analysismonovariate analysis))
Факторы риска Frequency
(N=642)
OR Confidence interval СI0.95
P value
Cases Controls
Blood transfusion 5.6% 0.2% 24.0 [3.1; 184.6] <0.001
Injections in hospital
5.6% 0.9% 7.6 [2.1; 27.6] <0.001
Injections in policlinic
22.0% 7.2% 3.5 [2.1; 5.8] <0.001
Surgeon 7.0% 1.6% 4.8 [1.9; 12.6] <0.001
Multiple sexual partners
4.7% 1.4% 8.7 [1.8; 41.9] <0.05
Risk Factors of Parenteral Risk Factors of Parenteral HepatitisHepatitis(2)(2)
Risk factors βίOR=e
Confidence interval СI0.95
P value
Blood transfusion 11.4 [1.3; 99.7] <0,05
Injections in hospital
3.2 [2.0; 5.9] <0,001
Injections in policlinic
5.7 [1.1; 15.9] <0,001
Surgeon 1.1 [0.2; 5.4] >0,05
Multiple sexual partners
5.2 [1.5; 17.6] <0,01
ConclusionConclusion
• Risk of parenterally transmitted viral hepatitis remains significant in health facilities. The system of blood and injection safety should be improved
• The system of health communication and training to improve understanding of natural Hep B transmission mechanisms and prevention measures should be strengthened (+HIV)
Hepatitis B Immunization Program Hepatitis B Immunization Program in Kyrgyzstanin Kyrgyzstan
• Introduced in April 1999
• High immunization coverage – > 95%
• 23 cases of acute HB among fully immunized children registered by routine surveillance
Surveillance
Routine(syndrome based)
Sentinel(laboratory based)
High sensitivity
(95%)
Low specificity
(17%)
Lowsensitivity
(7%)
High specificity
(87%)
Materials and MethodsMaterials and Methods (2) (2)
• Comparison of acute hepatitis B incidence rates among vaccinated and unvaccinated children born in sentinel sites between 2000 and 2003
• Analyses of acute hepatitis B incidence among children under 5 years of age in sentinel sites for the period 2000 to 2003
– Hepatitis B cases: acute hepatitis sentinel surveillance database
– Vaccination status of acute hepatitis B cases: primary health facility immunization records
– Number of children in age groups and vaccination status of non-infected children: official statistical data of the Ministry of Health
Acute Hepatitis B Cases Among Acute Hepatitis B Cases Among Children Under 4,Children Under 4,
Sentinel Surveillance,Sentinel Surveillance, 2000-2003 2000-2003Sentinel sites Number of
children under 4
Children born after April 1999
Children fully immunized
Bishkek 15 4 0Dzalal-Abad 33 9 2Naryn 5 1 0Total: 53 14 2
Incidence rates among vaccinated and Incidence rates among vaccinated and unvaccinated children, Bishkek, Naryn, Jalalabat unvaccinated children, Bishkek, Naryn, Jalalabat , ,
2000-2003 2000-2003
Number of children born in 2000-2003 37 784
Number of fully vaccinated children 37 112
Number unvaccinated children 672
Number of acute HB cases among vaccinated children
2
Number of acute HB cases among unvaccinated children
12
Incidence rate among vaccinated children 2.9 per 100,000 child-years
Incidence rate among unvaccinated children 760.0 per 100,000 child-years
Acute Hepatitis Incidence Among Acute Hepatitis Incidence Among children under 5, 2000-2003children under 5, 2000-2003
47,4
18,8
75,1
26
46
66
86
0
5
10
15
20
25
30
35
40
45
50
2000 2001 2002 2003
%
0
10
20
30
40
50
60
70
80
90
100
Mo
rbid
ity
rati
o %
000
VHB morbidity rate VHB immunization coverage
Conclusions Conclusions (1)(1)
• AHSS allows effective MONITORING of immunization program in sentinel sites, providing the ability to: – carry out epidemiological investigation of every
case of acute viral Hepatitis B– identify and quickly respond to immunization
program errors
ConclusionsConclusions (2) (2)
KAHSS provides:
• the ability to EVALUATE the impact of an immunization program
• an advocacy tool to support the necessity of sustainable immunization programs
Study LimitationsStudy Limitations
• Evaluation of risk factors:– Use of acute hepatitis A cases as controls; – Aggregation of acute hepatitis B, C and D
cases into one group of parenteral hepatitis
• Evaluation of Immunization program:– Use of official statistical data to define the
size of target age groups and vaccinated and unvaccinated children
AcknowledgementsAcknowledgements
• The Ministry of Health of the Kyrgyz Republic
• Republican Center for Viral Hepatitis Prevention
• State Department of Sanitation and Epidemiological Surveillance
• Republican Center for Immunization